Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
The U.S. Meals and Drug Administration (FDA) has accepted PD-L1 IHC 22C3 pharmDx, Code SK006, as a companion diagnostic to assist establish sufferers with epithelial...
New analysis has recognized two “crimson flag” signs that present up in practically half of all early-onset colorectal most cancers circumstances: stomach...
The FDA has granted quick observe designation to SYNC-T SV-102 remedy (Syncromune Inc.) for the therapy of metastatic castration-resistant prostate most cancers (mCRPC)....
SACRAMENTO – Senate President professional Tempore Emeritus Toni G. Atkins (D-San Diego) has launched laws to develop entry to breast and cervical most...
